Evaluation of a glycoengineered monoclonal antibody via LC-MS analysis in combination with multiple enzymatic digestion

Glycosylation affects the efficacy, safety and pharmacokinetics/pharmacodynamics properties of therapeutic monoclonal antibodies (mAbs), and glycoengineering is now being used to produce mAbs with improved efficacy. In this work, a glycoengineered version of rituximab was produced by chemoenzymatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Renpeng, Giddens, John, McClung, Colleen M., Magnelli, Paula E., Wang, Lai-Xi, Guthrie, Ellen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966608/
https://www.ncbi.nlm.nih.gov/pubmed/26514686
http://dx.doi.org/10.1080/19420862.2015.1113361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966608/
https://www.ncbi.nlm.nih.gov/pubmed/26514686
http://dx.doi.org/10.1080/19420862.2015.1113361

Ejemplares similares